Historical record - last NADAC effective date: 9/22/2021

Product Information

NYSTATIN 100,000 UNIT/ML SUSP is a generic product labeled by Pharmaceutical Associates, Inc., priced at $0.0561 per ML under NDC 00121081016. Its NADAC has been published 261 times since Oct 5, 2016.

FDA first approved this application on Jan 7, 2016. Its Orange Book therapeutic-equivalence code is AA.

NYSTATIN 100,000 UNIT/ML SUSP

NYSTATIN
$0.0561per ML

Strength

100000 [USP'U]/mL

NDC

00121081016

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

9/22/2021

Active Ingredients

NYSTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA203621

FDA Approved

1/7/2016

TE Code

AA

On Market Since

2/1/2016

Pharmacological Classes

Price Statistics

The NADAC for NYSTATIN 100,000 UNIT/ML SUSP has been published 261 times since Oct 5, 2016, and over the history we have for it it has declined 10.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0561 per ML
All-time high$0.0849 (May 13, 2020)
All-time low$0.0524 (Jun 23, 2021)
Median price$0.0642
Average price$0.0656
Largest weekly change+50.7% (Oct 21, 2020)
Weeks tracked261
Tracking sinceOct 5, 2016

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-10.7%

Last surveyed Sep 29, 2021 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NYSTATIN 100,000 UNIT/ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/ML SUSP, manufactured by Pharmaceutical Associates, Inc., is $0.0561 per ML (NDC 00121081016), effective Sep 29, 2021.

How has the price of NYSTATIN 100,000 UNIT/ML SUSP changed over time?

Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has declined 10.7%. It has been tracked across 261 weekly CMS publications since Oct 5, 2016.

What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/ML SUSP?

Since Oct 5, 2016, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has ranged from a low of $0.0524 (Jun 23, 2021) to a high of $0.0849 (May 13, 2020), with a median of $0.0642 per ML.

Are there cheaper alternatives to NYSTATIN 100,000 UNIT/ML SUSP?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN 100,000 UNIT/ML SUSP, is $0.0529 per ML — about 6% below NYSTATIN 100,000 UNIT/ML SUSP.

Who manufactures NYSTATIN 100,000 UNIT/ML SUSP?

NYSTATIN 100,000 UNIT/ML SUSP (NDC 00121081016) is labeled by Pharmaceutical Associates, Inc., and CMS classifies it as a generic product.